Biotech startups are built on venture capital. Track funding rounds here.; Will Walgreens’ store closures disrupt its clinical trial aims?; Lexicon to disband sales team, lay off 60% of staff
See the ways Chromium Single Cell innovations deliver superior performance while driving down costs and taking throughput to new heights.
Find out more.
Evotec appears to have rebuffed Halozyme’s $2.1 billion acquisition attempt. Elsewhere, Argenx has another blockbuster target in sight and an FDA veteran plans retirement.
Venture capital firms incubate, grow and finance dozens of drug companies each year. Follow the money they channel into the industry with this database.
Learn how the optimal NGS solution can help you hit your milestones during clinical trials, throughout CDx development and into global commercialization.
The restructuring follows the company's receipt of a letter from the FDA citing "deficiencies" in its approval application for diabetes drug Zynquista.
